An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data

Karen E. Bremner, Murray D. Krahn, Joan L. Warren, Jeffrey S Hoch, Michael J. Barrett, Ning Liu, Lisa Barbera, K. Robin Yabroff

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Patterns of end-of-life cancer care differ in Canada and the United States; yet little is known about differences in service-specific and overall costs. Aim: The aim of this study was to compare end-of-life costs in Ontario, Canada, and the United States, using administrative health data. Design: Advanced-stage nonsmall cell lung cancer patients who died from cancer at age ≥65.5 years in 2001-2005 were selected from the US Surveillance, Epidemiology, and End Results-Medicare database (N = 16,858) and the Ontario Cancer Registry (N = 8643). We estimated total and service-specific costs (2009 US dollars) in each of the last 6 months of life from the public payer perspectives for short-term and long-term survivors (lived <180 and ≥180 days post-diagnosis, respectively). Services were defined for comparisons between systems. Results: Mean monthly costs increased as death approached, were higher in short-term than long-term survivors, and were generally higher in the United States than in Ontario until the month before death, when they were similar (long-term survivors: US$10,464 and US$10,094 (p = 0.53), short-term survivors US$14,455 and US$12,836 (p = 0.11), in Surveillance, Epidemiology, and End Results-Medicare and Ontario, respectively). Costs for Medicare hospice and Ontario's palliative care components were similar and increased closer to death. Inpatient hospitalization was the main cost driver with similar costs in both cohorts, despite lower utilization in the United States. The compositions of many services and costs differed. Conclusion: Costs for nonsmall cell lung cancer patients were slightly higher in the United States than Ontario until 1 month before death. Administrative data allow exploration and international comparisons of reimbursement policies, health-care delivery, and costs at the end of life.

Original languageEnglish (US)
Pages (from-to)918-928
Number of pages11
JournalPalliative Medicine
Volume29
Issue number10
DOIs
StatePublished - Dec 1 2015
Externally publishedYes

Fingerprint

Terminal Care
Lung Neoplasms
Ontario
Costs and Cost Analysis
Health
Survivors
Medicare
Non-Small Cell Lung Carcinoma
Canada
Epidemiology
Neoplasms
Hospices
Palliative Care
Health Care Costs
Registries
Inpatients
Hospitalization
Databases
Delivery of Health Care

Keywords

  • comparative study
  • costs and cost analysis
  • health services
  • nonsmall cell lung carcinoma
  • Terminal care

ASJC Scopus subject areas

  • Medicine(all)
  • Anesthesiology and Pain Medicine

Cite this

An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data. / Bremner, Karen E.; Krahn, Murray D.; Warren, Joan L.; Hoch, Jeffrey S; Barrett, Michael J.; Liu, Ning; Barbera, Lisa; Yabroff, K. Robin.

In: Palliative Medicine, Vol. 29, No. 10, 01.12.2015, p. 918-928.

Research output: Contribution to journalArticle

Bremner, Karen E. ; Krahn, Murray D. ; Warren, Joan L. ; Hoch, Jeffrey S ; Barrett, Michael J. ; Liu, Ning ; Barbera, Lisa ; Yabroff, K. Robin. / An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data. In: Palliative Medicine. 2015 ; Vol. 29, No. 10. pp. 918-928.
@article{fcff14a684d047c999e1e8f883007fc5,
title = "An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data",
abstract = "Background: Patterns of end-of-life cancer care differ in Canada and the United States; yet little is known about differences in service-specific and overall costs. Aim: The aim of this study was to compare end-of-life costs in Ontario, Canada, and the United States, using administrative health data. Design: Advanced-stage nonsmall cell lung cancer patients who died from cancer at age ≥65.5 years in 2001-2005 were selected from the US Surveillance, Epidemiology, and End Results-Medicare database (N = 16,858) and the Ontario Cancer Registry (N = 8643). We estimated total and service-specific costs (2009 US dollars) in each of the last 6 months of life from the public payer perspectives for short-term and long-term survivors (lived <180 and ≥180 days post-diagnosis, respectively). Services were defined for comparisons between systems. Results: Mean monthly costs increased as death approached, were higher in short-term than long-term survivors, and were generally higher in the United States than in Ontario until the month before death, when they were similar (long-term survivors: US$10,464 and US$10,094 (p = 0.53), short-term survivors US$14,455 and US$12,836 (p = 0.11), in Surveillance, Epidemiology, and End Results-Medicare and Ontario, respectively). Costs for Medicare hospice and Ontario's palliative care components were similar and increased closer to death. Inpatient hospitalization was the main cost driver with similar costs in both cohorts, despite lower utilization in the United States. The compositions of many services and costs differed. Conclusion: Costs for nonsmall cell lung cancer patients were slightly higher in the United States than Ontario until 1 month before death. Administrative data allow exploration and international comparisons of reimbursement policies, health-care delivery, and costs at the end of life.",
keywords = "comparative study, costs and cost analysis, health services, nonsmall cell lung carcinoma, Terminal care",
author = "Bremner, {Karen E.} and Krahn, {Murray D.} and Warren, {Joan L.} and Hoch, {Jeffrey S} and Barrett, {Michael J.} and Ning Liu and Lisa Barbera and Yabroff, {K. Robin}",
year = "2015",
month = "12",
day = "1",
doi = "10.1177/0269216315596505",
language = "English (US)",
volume = "29",
pages = "918--928",
journal = "Palliative Medicine",
issn = "0269-2163",
publisher = "SAGE Publications Ltd",
number = "10",

}

TY - JOUR

T1 - An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data

AU - Bremner, Karen E.

AU - Krahn, Murray D.

AU - Warren, Joan L.

AU - Hoch, Jeffrey S

AU - Barrett, Michael J.

AU - Liu, Ning

AU - Barbera, Lisa

AU - Yabroff, K. Robin

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Background: Patterns of end-of-life cancer care differ in Canada and the United States; yet little is known about differences in service-specific and overall costs. Aim: The aim of this study was to compare end-of-life costs in Ontario, Canada, and the United States, using administrative health data. Design: Advanced-stage nonsmall cell lung cancer patients who died from cancer at age ≥65.5 years in 2001-2005 were selected from the US Surveillance, Epidemiology, and End Results-Medicare database (N = 16,858) and the Ontario Cancer Registry (N = 8643). We estimated total and service-specific costs (2009 US dollars) in each of the last 6 months of life from the public payer perspectives for short-term and long-term survivors (lived <180 and ≥180 days post-diagnosis, respectively). Services were defined for comparisons between systems. Results: Mean monthly costs increased as death approached, were higher in short-term than long-term survivors, and were generally higher in the United States than in Ontario until the month before death, when they were similar (long-term survivors: US$10,464 and US$10,094 (p = 0.53), short-term survivors US$14,455 and US$12,836 (p = 0.11), in Surveillance, Epidemiology, and End Results-Medicare and Ontario, respectively). Costs for Medicare hospice and Ontario's palliative care components were similar and increased closer to death. Inpatient hospitalization was the main cost driver with similar costs in both cohorts, despite lower utilization in the United States. The compositions of many services and costs differed. Conclusion: Costs for nonsmall cell lung cancer patients were slightly higher in the United States than Ontario until 1 month before death. Administrative data allow exploration and international comparisons of reimbursement policies, health-care delivery, and costs at the end of life.

AB - Background: Patterns of end-of-life cancer care differ in Canada and the United States; yet little is known about differences in service-specific and overall costs. Aim: The aim of this study was to compare end-of-life costs in Ontario, Canada, and the United States, using administrative health data. Design: Advanced-stage nonsmall cell lung cancer patients who died from cancer at age ≥65.5 years in 2001-2005 were selected from the US Surveillance, Epidemiology, and End Results-Medicare database (N = 16,858) and the Ontario Cancer Registry (N = 8643). We estimated total and service-specific costs (2009 US dollars) in each of the last 6 months of life from the public payer perspectives for short-term and long-term survivors (lived <180 and ≥180 days post-diagnosis, respectively). Services were defined for comparisons between systems. Results: Mean monthly costs increased as death approached, were higher in short-term than long-term survivors, and were generally higher in the United States than in Ontario until the month before death, when they were similar (long-term survivors: US$10,464 and US$10,094 (p = 0.53), short-term survivors US$14,455 and US$12,836 (p = 0.11), in Surveillance, Epidemiology, and End Results-Medicare and Ontario, respectively). Costs for Medicare hospice and Ontario's palliative care components were similar and increased closer to death. Inpatient hospitalization was the main cost driver with similar costs in both cohorts, despite lower utilization in the United States. The compositions of many services and costs differed. Conclusion: Costs for nonsmall cell lung cancer patients were slightly higher in the United States than Ontario until 1 month before death. Administrative data allow exploration and international comparisons of reimbursement policies, health-care delivery, and costs at the end of life.

KW - comparative study

KW - costs and cost analysis

KW - health services

KW - nonsmall cell lung carcinoma

KW - Terminal care

UR - http://www.scopus.com/inward/record.url?scp=84948151639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948151639&partnerID=8YFLogxK

U2 - 10.1177/0269216315596505

DO - 10.1177/0269216315596505

M3 - Article

C2 - 26330452

AN - SCOPUS:84948151639

VL - 29

SP - 918

EP - 928

JO - Palliative Medicine

JF - Palliative Medicine

SN - 0269-2163

IS - 10

ER -